Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

PHASE4CompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

July 7, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG

Lisdexamfetamine dimesylate

Optimized dose of either 30, 50 or 70 mg capsule administered once daily for 2 years

Trial Locations (35)

2660

ZNA Antwerpen, Commandant Weynsstraat 165 Campus Hoge Beuken, Hoboken

13353

Universitätsmedizin Berlin, Berlin

14186

Paediatric Neurology Children's Hospital in Huddinge, Stockholm

22415

Praxis Dr. med. Friedrich Kaiser und Dr. med. Ingrid Marinesse, Hamburg

29620

Hospital Maritimo de Torremolinos, Torremolinos

31008

Clinica Universitaria de Navarra, Unidad de Psiquiatría Infantil y Adolescente, Dept. de Psiquiatria y Psicologia Medica Avenida Pio XII 36 Apartado 4209 Pamplona, Pamplona

38320

Hospital Univeritario de Canarias, Consultas Externas de Psiquiatria Ofra l La Cuesta s/n San Cristobal de la Laguna Laguna Santa Cruz, San Cristóbal de La Laguna

41118

Child Neuropsychiatry Centre The Queen Silvia Children's Hospita Otterhallegatan 12A, Gothenburg

41914

"Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia", Bucharest

43530

Barn och Ungdomsmedicin klinik Molnlycke Ekdalavagen 2 Box 9, Mölnlycke

58093

Praxis Dr.Christian Wolff, Hagen

68159

Zentralinstitut für Seelische Gesundheit Mannheim, Mannheim

79104

Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau

96047

Schwerpunktpraxis für Entwicklung und Lernen, Bamberg

97070

Medizinisches Studienzentrum Würzburg, Würzburg

98125

Azienda Ospedaliera Universitaria Policlinico G. Martino, Messina

300011

"Spitalul Clinic de Urgenta pentru Copii Louis Turcanu", Timișoara

B-3000

Afdeling Psychiatrie, Leuven

H-7633

Gyermek es Ifjusagpszichiatriai Szakrendeles es Gondozo Veress E. u. 2., Pécs

H-6720

Szegedi Tudomanyegyetem, Gyermek- es Ifjusagpszichiatriai Osztaly Boldogasszony sgt. 15, Szeged

H-1021

Vadaskert Korhaz es Szakambulancia, Gyermek es Ifjusagpszichiatria Huvosvolgyi ut 116, Budapest

H-5700

Pandy Kalman Korhaz, Gyermekpszichiatria Semmelweis u.1., Gyula

09124

Azienda Ospedaliero-Universitaria di Cagliari, Cagliari

6419XZ

Academisch Ziekenhuis Maastricht, Heerlen

85-094

Szpital Uniwersytecki im. dr. Antoniego Jurasza w Bydgoszczy, Bydgoszcz

87-100

Wojewodzki Osrodek Lecznictwa Psychiatrycznego W Toruniu, Torun

00-576

Samodzielny Publiczny Dzieciecy Szpital Kliniczny, Warsaw

Unknown

Spitalul Clinic de Psihiatrie Socola, Iași

07198

Hospital Son Llàtzer, Palma de Mallorca

08950

Hospital Sant Joan de Deu, Servicio de Psiquiatria Infantil Passeig Sant Joan de Deu, 2 Esplugues de Llobregat, Esplugues de Llobregat

08221

Mutua de Terrassa, Centro de Salud Mental Cap Rambla Psiquiatria Infantil Placa Doctor Robert, 5, Terrassa

06010

Complejo Hospitalario Universitario de Badajoz, Badajoz

08036

Hospital Clinic I Provincial de Barcelona, Barcelona

RM16 2PX

Thurrock Hospital, Grays

DD3 6HH

University of Dundee, Centre for Child Health 19 Dudhope Terrace Scotland, Dundee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT01328756 - Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter